Elekta Inc.

Elekta Inc., doing business as Elekta Instruments, Inc., manufactures and supplies radiation therapy linear accelerators, stereotactic radiosurgery systems, MRI-LINAC imaging-therapy integrated platforms, treatment planning software, and oncology information systems to the Department of Veterans Affairs and other federal healthcare agencies as a prime contractor (99% of recent awards). Elekta is a Sweden-based for-profit medical technology manufacturer, headquartered in Atlanta, Georgia, competing full-and-open across its federal footprint with no small-business set-aside designations; the company operates as an OEM and sole authorized provider of its proprietary oncology equipment and software across federal healthcare networks.

Elekta's federal customer base concentrates heavily in the VA system. Five VA Veterans Integrated Service Networks and the VA National Acquisition Center account for 36% of recent awards by count, representing 68% of combined potential value. VISN 12 dominates the relationship, anchoring 34 awards valued at $114.1 million in combined potential value, followed distantly by VISN 20 (33 awards, $6.2 million) and VISN 2 (30 awards, $8.1 million). The National Cancer Institute, within HHS/NIH, ranks third by dollars ($12.4 million across 16 awards) but fifth by award count, reflecting larger single-procurements for capital equipment. Elekta has also worked with the Department of Defense through the Medical Supply Chain and Defense Health Agency, as well as the Uniformed Services University of the Health Sciences and the Armed Forces Radiobiology Research Institute. Recent representative work includes a $10.65 million definitive contract from the National Cancer Institute (awarded September 2026) for acquisition and installation of a 1.5 Tesla MR-LINAC system at the NIH Clinical Center in Bethesda, Maryland, including site planning, shielding, delivery, installation, commissioning, and 12-month warranty; a $7.24 million delivery order from the National Acquisition Center (October 2025) for an MRI-LINAC system to Lexington, Kentucky, under the VISN 12 IDC; and a $3.47 million delivery order from the National Acquisition Center (May 2026) for radiation therapy linear accelerator and CT equipment, also for Lexington, under the same vehicle.

Elekta holds five named parent IDCs with federal agencies. The $60 million VISN 12 Radiation Therapy Equipment Systems and Accessories multiple-award IDIQ (awarded September 2025, completion September 2030) has generated four documented delivery orders totaling approximately $13.8 million and covers linear accelerators, simulator systems, treatment planning systems, brachytherapy systems, stereotactic radiosurgery systems, upgrades, accessories, installation, service, maintenance, and training. An $8 million single-award IDC from the Department of Defense Medical Supply Chain (awarded September 2025, completion September 2035) encompasses the full Elekta portfolio—linear accelerators, stereotactic radiosurgery equipment, MRI-LINAC systems, treatment planning software, and oncology information systems—with performance spanning CONUS, Alaska, Hawaii, U.S. territories, and potentially OCONUS locations. A $6 million single-award IDC from the VA VISN 12 (expired September 2025) previously supported radiation therapy equipment and systems procurement. Another $6 million single-award IDC from the Defense Medical Supply Chain (awarded September 2024, completion September 2025) served a similar purpose. A smaller $94,205 single-award IDIQ with VA VISN 12 (awarded December 2022, completion November 2027) covers MOSAIQ to Cerner/FedEHR interface design, configuration, testing, installation, training, and maintenance at the Milwaukee VA Medical Center, with one documented delivery order of $45,599.50.

Activity has remained moderate but stable. The past five years show fluctuation—12 awards in 2022, declining to 4 in 2024, rebounding to 12 in 2025, then 8 in 2026 (through September)—indicating irregular demand for capital equipment rather than sustained growth. Fifteen awards with ultimate completion dates in the next twenty-four months carry combined potential value of $29.3 million, representing moderate recompete exposure. Elekta's federal portfolio spans 37 distinct customer agencies and includes 383 total awards (prime and sub) valued at $253.7 million in combined potential value, with $107.3 million obligated to date (42% of potential value).

NAICS concentration reflects Elekta's medical-device manufacturing posture. The top-five NAICS codes are Other Measuring and Controlling Device Manufacturing (69 awards), Other Electronic and Precision Equipment Repair and Maintenance (68 awards), Electromedical and Electrotherapeutic Apparatus Manufacturing (39 awards), Irradiation Apparatus Manufacturing (38 awards), and Surgical and Medical Instrument Manufacturing (28 awards). PSC codes cluster in Medical and Surgical Instruments, Equipment, and Supplies (105 awards), Maintenance/Repair/Rebuild of Medical, Dental, and Veterinary Equipment (97 awards), and Imaging Equipment and Supplies (52 awards).

SCI-reported federal service-contract activity shows minimal scale relative to Elekta's product-focused footprint. SCI covers 23 prime service contracts above the $150,000 reporting threshold across FY2022–FY2025, with total invoiced revenue of $4.6 million ($0 in FY2022; $1.1 million in FY2023; $1.3 million in FY2024; $2.1 million in FY2025). Workforce delivery ran 0.6 FTEs in FY2023, 0.5 FTEs in FY2024, and 0.7 FTEs in FY2025. Government-paid hourly rates on SCI contracts ranged from $427.54/hr at the tenth percentile to a median of $1,382.67/hr and $6,624.47/hr at the ninetieth percentile, reflecting a mix of field service technician and specialist labor. Across SCI-reportable prime contracts, Elekta performed 0% of hours through subcontractors, self-delivering all labor. At the grant level, Elekta acts as a sub-recipient on two federal research awards: a Johns Hopkins University grant subaward (January 2026) for changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placement, and a Medical College of Wisconsin subaward (September 2024) for machine learning accelerated online adaptive replanning.